HSXAX | VEMAX | HSXAX / VEMAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 18 years | - |
Gain YTD | 7.026 | 10.504 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 60.8M | 113B | 0% |
Annual Yield % from dividends | 1.28 | 3.43 | 37% |
Returns for 1 year | 10.98 | 14.72 | 75% |
Returns for 3 years | N/A | -7.36 | - |
Returns for 5 years | N/A | 16.89 | - |
Returns for 10 years | N/A | 27.25 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SNEMX | 27.35 | -0.09 | -0.33% |
AB Emerging Markets | |||
SEEIX | 12.48 | -0.09 | -0.72% |
SEI International Equity I (SIT) | |||
TBCIX | 199.38 | -4.44 | -2.18% |
T. Rowe Price Blue Chip Growth I | |||
HSLAX | 46.26 | -1.04 | -2.20% |
Hartford Small Cap Growth A | |||
BIPIX | 60.79 | -5.27 | -7.98% |
ProFunds Biotechnology UltraSector Inv |